Company Directory / Pharmaceuticals

BDR Pharmaceuticals Internationals logo

PrivateFor profitPharmaceuticalsMumbai, India

BDR Pharmaceuticals Internationals

BDR Group is engaged in the development of specialized therapeutic segments, viz. oncology, critical care, gynecology, and neurology.

Founded
2003
23 years ago
Staff
101-250
770 on LinkedIn
Followers
13k
on LinkedIn
Funding
-
none listed

Majorly Deals into API and Finish Formulation.

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

101-250 people: larger than 85% of companies with a size listed. 770 people list it on LinkedIn.

Age

200319002026

23 years old.

Reach

Website ranked #4,667,621 in the world for traffic, about 2k visits a month. 13,369 followers on LinkedIn.

What it does

BiotechnologyHealth CareOncologyPharmaceutical

Funding, as listed

Undisclosed raised in total

  • Rounds1
  • LatestPrivate equity, Apr 2022
  • Investors7

What the source datasets report. We have not watched these rounds ourselves.

FoundersDharmesh Shah

Every detail we hold

Everything the source datasets list about BDR Pharmaceuticals Internationals, field by field. Contact details are held but never shown.

The company

Name
BDR Pharmaceuticals Internationals
Type
For profit
Status
Private
Founded
2003
Founders
Dharmesh Shah
Industry
Pharmaceuticals
Categories
Biotechnology, Health Care, Oncology, Pharmaceutical

Where

City
Mumbai
Country
India
Markets
Asia-Pacific (APAC)

Size and reach

Staff band
101-250
People on LinkedIn
770
LinkedIn followers
13,369
Web traffic rank
#4,667,621
Monthly web visits
2,017

Funding, as listed

Rounds
1
Latest round
Private equity
Latest round date
Apr 2022
Investors
7
Listing status
private

About this record

Sources
Crunchbase, LinkedIn
Last imported
Sept 2026

Growth, as the source summarises it

BDR Pharmaceuticals Internationals may be growing as it has recently launched a new prostate cancer drug in oral solution form, which could indicate an expansion of its product portfolio in the oncology segment. This launch may contribute to the company's revenue growth and strengthen its position in the pharmaceutical industry. Additionally, the introduction of new products is a positive sign of a company's innovation and ability to meet market demands.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

Pharmaceuticals in India.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 139,726 companies in India and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.